This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Geistlich Pharma, Geistlich Pharma Ag. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Martin Wuest: Innovator in Collagen Technology
Introduction
Martin Wuest is a notable inventor based in Emmenbrücke, Switzerland. He has made significant contributions to the field of biomedical engineering, particularly in the development of innovative collagen-based materials. With a total of 2 patents to his name, Wuest's work focuses on enhancing soft tissue augmentation techniques.
Latest Patents
Wuest's latest patents include a resilient resorbable chemically crosslinked collagen sponge designed for promoting soft tissue volume augmentation in the oral region. This sponge comprises 60-96% (w/w) collagen and 4-40% (w/w) elastin. It features interconnected pores with a median pore diameter between 50 and 90 µm and at least 80% porosity, with a pore diameter exceeding 10 µm. The sponge has an onset temperature ranging from 45 to 57°C and a density in the dry state of 50 to 65 mg/cm. Additionally, he has developed a process for preparing this collagen sponge and a method for using it as an implant in the oral cavity for soft tissue volume augmentation.
Career Highlights
Throughout his career, Martin Wuest has worked with prominent companies in the biomedical sector, including Geistlich Pharma and Geistlich Pharma AG. His expertise in collagen technology has positioned him as a key player in the development of innovative solutions for soft tissue augmentation.
Collaborations
Wuest has collaborated with notable professionals in his field, including Niklaus Stiefel and Cornel Imhof. These collaborations have further enhanced his research and development efforts in collagen-based materials.
Conclusion
Martin Wuest's contributions to collagen technology and soft tissue augmentation are noteworthy. His innovative patents and collaborations reflect his commitment to advancing biomedical engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile